A citation-based method for searching scientific literature

Lars-Åke Levin, Lars Wallentin, Lars Bernfort, David Andersson, Robert F Storey, Gina Bergström, Carl-Johan Lamm, Magnus Janzon, Padma Kaul. Value Health 2013
Times Cited: 18







List of co-cited articles
89 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
Lars Wallentin, Richard C Becker, Andrzej Budaj, Christopher P Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo Katus,[...]. N Engl J Med 2009
50

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study.
Elisabet Nikolic, Magnus Janzon, Ole Hauch, Lars Wallentin, Martin Henriksson. Eur Heart J 2013
59
33

Prasugrel versus clopidogrel in patients with acute coronary syndromes.
Stephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, Gilles Montalescot, Witold Ruzyllo, Shmuel Gottlieb, Franz-Joseph Neumann, Diego Ardissino, Stefano De Servi, Sabina A Murphy,[...]. N Engl J Med 2007
33


Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.
Lars Wallentin, Stefan James, Robert F Storey, Martin Armstrong, Bryan J Barratt, Jay Horrow, Steen Husted, Hugo Katus, P Gabriel Steg, Svati H Shah,[...]. Lancet 2010
470
22

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy.
M Janzon, S James, C P Cannon, R F Storey, C Mellström, J C Nicolau, L Wallentin, M Henriksson. Heart 2015
8
50

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
Robert F Storey, Steen Husted, Robert A Harrington, Stanley Heptinstall, Robert G Wilcox, Gary Peters, Mark Wickens, Håkan Emanuelsson, Paul Gurbel, Peer Grande,[...]. J Am Coll Cardiol 2007
312
22

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
S Yusuf, F Zhao, S R Mehta, S Chrolavicius, G Tognoni, K K Fox. N Engl J Med 2001
22

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
Stefan James, Axel Akerblom, Christopher P Cannon, Håkan Emanuelsson, Steen Husted, Hugo Katus, Allan Skene, Philippe Gabriel Steg, Robert F Storey, Robert Harrington,[...]. Am Heart J 2009
254
16

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.
Paul A Gurbel, Kevin P Bliden, Kathleen Butler, Mark J Antonino, Cheryl Wei, Renli Teng, Lars Rasmussen, Robert F Storey, Tonny Nielsen, John W Eikelboom,[...]. Circulation 2010
295
16

Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy).
Robert F Storey, Richard C Becker, Robert A Harrington, Steen Husted, Stefan K James, Frank Cools, Philippe Gabriel Steg, Nardev S Khurmi, Hakan Emanuelsson, Soo Teik Lim,[...]. Am J Cardiol 2011
46
16



Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.
Robert F Storey, Kevin P Bliden, Shankar B Patil, Arun Karunakaran, Rosemary Ecob, Kathleen Butler, Renli Teng, Cheryl Wei, Udaya S Tantry, Paul A Gurbel. J Am Coll Cardiol 2010
110
16

Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial.
Steen Husted, Stefan James, Richard C Becker, Jay Horrow, Hugo Katus, Robert F Storey, Christopher P Cannon, Magda Heras, Renato D Lopes, Joao Morais,[...]. Circ Cardiovasc Qual Outcomes 2012
101
16

Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study.
Dimitrios Alexopoulos, Anastasia Galati, Ioanna Xanthopoulou, Eleni Mavronasiou, George Kassimis, Konstantinos C Theodoropoulos, George Makris, Anastasia Damelou, Grigorios Tsigkas, George Hahalis,[...]. J Am Coll Cardiol 2012
148
16

Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial.
P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, Hugo A Katus, Kenneth W Mahaffey, Bernhard Meier, Robert F Storey, Daniel M Wojdyla, Basil S Lewis, Gerald Maurer,[...]. Circulation 2013
83
16

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.
Paul A Gurbel, Kevin P Bliden, Kathleen Butler, Udaya S Tantry, Tania Gesheff, Cheryl Wei, Renli Teng, Mark J Antonino, Shankar B Patil, Arun Karunakaran,[...]. Circulation 2009
706
16

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.
Steen Husted, Stefan K James, Richard G Bach, Richard C Becker, Andrzej Budaj, Magda Heras, Anders Himmelmann, Jay Horrow, Hugo A Katus, Riita Lassila,[...]. Eur Heart J 2014
37
16

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, Richard C Becker, Robert F Storey, Dominick J Angiolillo, Claes Held, Christopher P Cannon, Stefan James, Karen S Pieper,[...]. Circulation 2011
257
16


2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Ezra A Amsterdam, Nanette K Wenger, Ralph G Brindis, Donald E Casey, Theodore G Ganiats, David R Holmes, Allan S Jaffe, Hani Jneid, Rosemary F Kelly, Michael C Kontos,[...]. Circulation 2014
511
16


Patients' preferences in anticoagulant therapy: discrete choice experiment.
Mehdi Najafzadeh, Joshua J Gagne, Niteesh K Choudhry, Jennifer M Polinski, Jerry Avorn, Sebastian S Schneeweiss. Circ Cardiovasc Qual Outcomes 2014
17
17



Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index.
A Simon Pickard, Jeffrey A Johnson, David H Feeny, Ashfaq Shuaib, K C Carriere, Abdul M Nasser. Stroke 2004
127
16


ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Ph Gabriel Steg, Stefan K James, Dan Atar, Luigi P Badano, Carina Blömstrom-Lundqvist, Michael A Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles,[...]. Eur Heart J 2012
11

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.
Robert F Storey, Richard C Becker, Robert A Harrington, Steen Husted, Stefan K James, Frank Cools, Philippe Gabriel Steg, Nardev S Khurmi, Håkan Emanuelsson, Anna Cooper,[...]. Eur Heart J 2011
115
11

Why does ticagrelor induce dyspnea?
Marco Cattaneo, Elena M Faioni. Thromb Haemost 2012
52
11

Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study.
Marc Laine, Corinne Frère, Richard Toesca, Julie Berbis, Pierre Barnay, Michel Pansieri, Pierre Michelet, Jacques Bessereau, Elise Camilleri, Olivia Ronsin,[...]. Thromb Haemost 2014
45
11

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.
Richard C Becker, Jean Pierre Bassand, Andrzej Budaj, Daniel M Wojdyla, Stefan K James, Jan H Cornel, John French, Claes Held, Jay Horrow, Steen Husted,[...]. Eur Heart J 2011
215
11

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
Laurent Bonello, Udaya S Tantry, Rossella Marcucci, Ruediger Blindt, Dominick J Angiolillo, Richard Becker, Deepak L Bhatt, Marco Cattaneo, Jean Philippe Collet, Thomas Cuisset,[...]. J Am Coll Cardiol 2010
802
11

Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.
Guido Parodi, Renato Valenti, Benedetta Bellandi, Angela Migliorini, Rossella Marcucci, Vincenzo Comito, Nazario Carrabba, Alberto Santini, Gian Franco Gensini, Rosanna Abbate,[...]. J Am Coll Cardiol 2013
301
11

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Ezra A Amsterdam, Nanette K Wenger, Ralph G Brindis, Donald E Casey, Theodore G Ganiats, David R Holmes, Allan S Jaffe, Hani Jneid, Rosemary F Kelly, Michael C Kontos,[...]. J Am Coll Cardiol 2014
11

Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
Matthew T Roe, Jennifer A White, Padma Kaul, Pierluigi Tricoci, Yuliya Lokhnygina, Chadwick D Miller, Arnoud W van't Hof, Gilles Montalescot, Stefan K James, Jorge Saucedo,[...]. Circ Cardiovasc Qual Outcomes 2012
30
11

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
James W Shaw, Jeffrey A Johnson, Stephen Joel Coons. Med Care 2005
864
11

Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome.
Dhruv S Kazi, Alan M Garber, Rashmee U Shah, R Adams Dudley, Matthew W Mell, Ceron Rhee, Solomon Moshkevich, Derek B Boothroyd, Douglas K Owens, Mark A Hlatky. Ann Intern Med 2014
54
11

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.
Christopher P Cannon, Robert A Harrington, Stefan James, Diego Ardissino, Richard C Becker, Håkan Emanuelsson, Steen Husted, Hugo Katus, Matyas Keltai, Nardev S Khurmi,[...]. Lancet 2010
376
11

Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism.
S Nylander, E A Femia, M Scavone, P Berntsson, A-K Asztély, K Nelander, L Löfgren, R G Nilsson, M Cattaneo. J Thromb Haemost 2013
94
11


First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.
Udaya S Tantry, Kevin P Bliden, Cheryl Wei, Robert F Storey, Martin Armstrong, Kathleen Butler, Paul A Gurbel. Circ Cardiovasc Genet 2010
107
11

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
Matthew T Roe, Paul W Armstrong, Keith A A Fox, Harvey D White, Dorairaj Prabhakaran, Shaun G Goodman, Jan H Cornel, Deepak L Bhatt, Peter Clemmensen, Felipe Martinez,[...]. N Engl J Med 2012
514
11

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
Payal Kohli, Lars Wallentin, Eric Reyes, Jay Horrow, Steen Husted, Dominick J Angiolillo, Diego Ardissino, Gerald Maurer, Joao Morais, José C Nicolau,[...]. Circulation 2013
49
11

Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial.
Marc P Bonaca, Deepak L Bhatt, Eugene Braunwald, Marc Cohen, Philippe Gabriel Steg, Robert F Storey, Peter Held, Eva C Jensen, Marc S Sabatine. Am Heart J 2014
75
11


The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.
Benjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, Eric L Michelson, Robert A Harrington, Steen Husted, Stefan James, Hugo Katus, Prem Pais, Dimitar Raev,[...]. J Am Coll Cardiol 2011
79
11

Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
Jolanta M Siller-Matula, Julia Krumphuber, Bernd Jilma. Br J Pharmacol 2010
71
11

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.
Daniel Lindholm, Christoph Varenhorst, Christopher P Cannon, Robert A Harrington, Anders Himmelmann, Juan Maya, Steen Husted, Philippe Gabriel Steg, Jan H Cornel, Robert F Storey,[...]. Eur Heart J 2014
111
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.